Cargando…

Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania

BACKGROUND: Tanzania switched the antimalarial first line to sulphadoxine-pyrimethamine (SP) in 2001 from ineffective chloroquine (CQ). By 2003 higher levels of SP resistance were recorded, prompting an urgent need for replacing the first line drug with ACT, as currently recommended by the World Hea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kabanywanyi, Abdunoor M, Mwita, Alex, Sumari, Deborah, Mandike, Renata, Mugittu, Kefas, Abdulla, Salim
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194692/ https://www.ncbi.nlm.nih.gov/pubmed/17996121 http://dx.doi.org/10.1186/1475-2875-6-146

Ejemplares similares

Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania
por: Joseph, Deokary, et al.
Publicado: (2013)

Malaria prevalence in asymptomatic and symptomatic children in Kiwangwa, Bagamoyo district, Tanzania
por: Sumari, Deborah, et al.
Publicado: (2017)

Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania
por: Mugittu, Kefas, et al.
Publicado: (2006)

Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies
por: Mugittu, Kefas, et al.
Publicado: (2005)

Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
por: Kakolwa, Mwaka A., et al.
Publicado: (2018)

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania
por: Ishengoma, Deus S., et al.
Publicado: (2019)

Health worker factors associated with prescribing of artemisinin combination therapy for uncomplicated malaria in rural Tanzania
por: Selemani, Majige, et al.
Publicado: (2013)

Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study
por: Khatib, Rashid A, et al.
Publicado: (2012)

Residual Antimalarials in Malaria Patients from Tanzania – Implications on Drug Efficacy Assessment and Spread of Parasite Resistance
por: Hodel, Eva Maria, et al.
Publicado: (2009)

Intermittent preventive antimalarial treatment for children with anaemia
por: Athuman, Mwaka, et al.
Publicado: (2015)

Real-Time Fluorescence Loop Mediated Isothermal Amplification for the Diagnosis of Malaria
por: Lucchi, Naomi W., et al.
Publicado: (2010)

A systematic review of published antimalarial clinical trials: parasite clearance of artemisinin-containing regimens in the treatment of uncomplicated malaria
por: Das, Debashish, et al.
Publicado: (2012)

Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria in Uganda
por: Bukirwa, Hasifa, et al.
Publicado: (2006)

Artemisinin‐naphthoquine for treating uncomplicated Plasmodium falciparum malaria
por: Isba, Rachel, et al.
Publicado: (2015)

Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
por: Whegang, Solange Youdom, et al.
Publicado: (2010)

Pooled Multicenter Analysis of Cardiovascular Safety and Population Pharmacokinetic Properties of Piperaquine in African Patients with Uncomplicated Falciparum Malaria
por: Wattanakul, Thanaporn, et al.
Publicado: (2020)

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos
por: Mayxay, Mayfong, et al.
Publicado: (2012)

Application of community-based and integrated strategy to reduce malaria disease burden in southern Tanzania: the study protocol of China-UK-Tanzania pilot project on malaria control
por: Wang, Duoquan, et al.
Publicado: (2019)

Application of magnetic cytosmear for the estimation of Plasmodium falciparum gametocyte density and detection of asexual stages in asymptomatic children
por: Sumari, Deborah, et al.
Publicado: (2016)

Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania
por: Shayo, Alex, et al.
Publicado: (2015)

Efficacy and Safety of Artemisinin-Piperaquine for the Treatment of Uncomplicated Malaria: A Systematic Review
por: Wang, Qi, et al.
Publicado: (2020)

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
por: van der Pluijm, Rob W, et al.
Publicado: (2022)

High efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania
por: Mandara, Celine I., et al.
Publicado: (2018)

High cure rates and tolerability of artesunate–amodiaquine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania
por: Mandara, Celine I., et al.
Publicado: (2019)

Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children
por: Ashley, Elizabeth A, et al.
Publicado: (2008)

Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children
por: Maiteki-Sebuguzi, Catherine, et al.
Publicado: (2008)

Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar
por: Ménard, Didier, et al.
Publicado: (2007)

Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
por: Osorio, Lyda, et al.
Publicado: (2007)

Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa
por: Mwingira, Felista, et al.
Publicado: (2011)

World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria
por: Plowe, Christopher V, et al.
Publicado: (2007)

Artemether–lumefantrine and dihydroartemisinin–piperaquine treatment outcomes among children infected with uncomplicated Plasmodium falciparum malaria in Mwanza, Tanzania
por: Marwa, Karol J., et al.
Publicado: (2021)

Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure
por: Witmer, Kathrin, et al.
Publicado: (2020)

Artemisinin Antimalarials: Preserving the “Magic Bullet”
por: Maude, Richard J, et al.
Publicado: (2010)

DNA binding by the antimalarial compound artemisinin
por: Slavkovic, Sladjana, et al.
Publicado: (2022)

A Nationwide Survey of the Quality of Antimalarials in Retail Outlets in Tanzania
por: Kaur, Harparkash, et al.
Publicado: (2008)

Adherence to Artemisinin Combination Therapy for the treatment of uncomplicated malaria in the Democratic Republic of the Congo
por: Siddiqui, M. Ruby, et al.
Publicado: (2015)

Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
por: Kurth, Florian, et al.
Publicado: (2016)

Paediatric formulations of artemisinin‐based combination therapies for treating uncomplicated malaria in children
por: Bélard, Sabine, et al.
Publicado: (2020)

Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: A report from three study sites in sub-Saharan Africa
por: Ajayi, Ikeoluwapo O, et al.
Publicado: (2008)

Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
por: Stepniewska, Kasia, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_qm1l74d0eq4db7vfm38sqgc3nl